Publications

Filter Year

Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand.
Tormo J, Natarajan K, Margulies DH, Mariuzza RA. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402(6762): 623-31.
Predicting protein three-dimensional structure.
Moult J. 1999. Predicting protein three-dimensional structure. Current opinion in biotechnology 10(6): 583-8.
Physical and biological properties of cationic triesters of phosphatidylcholine.
MacDonald RC, Ashley GW, Shida MM, Rakhmanova VA, Tarahovsky YS, Pantazatos DP, Kennedy MT, Pozharski EV, Baker KA, Jones RD, et al. 1999. Physical and biological properties of cationic triesters of phosphatidylcholine. Biophysical journal 77(5): 2612-29.
The second type II module from human matrix metalloproteinase 2: structure, function and dynamics.
Briknarová K, Grishaev A, Bányai L, Tordai H, Patthy L, Llinás M. 1999. The second type II module from human matrix metalloproteinase 2: structure, function and dynamics. Structure (London, England : 1993) 7(10): 1235-45.
Multiple competition reactions for RPA order the assembly of the DNA polymerase delta holoenzyme.
Yuzhakov A, Kelman Z, Hurwitz J, O'Donnell M. 1999. Multiple competition reactions for RPA order the assembly of the DNA polymerase delta holoenzyme. The EMBO journal 18(21): 6189-99.
Some measures of comparative performance in the three CASPs.
Venclovas C, Zemla A, Fidelis K, Moult J. 1999. Some measures of comparative performance in the three CASPs. Proteins Suppl 3: 231-7.
Processing and analysis of CASP3 protein structure predictions.
Zemla A, Venclovas C, Moult J, Fidelis K. 1999. Processing and analysis of CASP3 protein structure predictions. Proteins Suppl 3: 22-9.
Critical assessment of methods of protein structure prediction (CASP): round III.
Moult J, Hubbard T, Fidelis K, Pedersen JT. 1999. Critical assessment of methods of protein structure prediction (CASP): round III. Proteins Suppl 3: 2-6.
Studies of the molecular mechanism of discrimination between cGMP and cAMP in the allosteric sites of the cGMP-binding cGMP-specific phosphodiesterase (PDE5).
Turko IV, Francis SH, Corbin JD. 1999. Studies of the molecular mechanism of discrimination between cGMP and cAMP in the allosteric sites of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). The Journal of biological chemistry 274(41): 29038-41.
Local electrostatic optimization in proteins.
Oliva MT, Moult J. 1999. Local electrostatic optimization in proteins. Protein engineering 12(9): 727-35.
Isolation and characterization of a split B-type DNA polymerase from the archaeon Methanobacterium thermoautotrophicum deltaH.
Kelman Z, Pietrokovski S, Hurwitz J. 1999. Isolation and characterization of a split B-type DNA polymerase from the archaeon Methanobacterium thermoautotrophicum deltaH. The Journal of biological chemistry 274(40): 28751-61.
The C-terminal region of Schizosaccaromyces pombe proliferating cell nuclear antigen is essential for DNA polymerase activity.
Kelman Z, Zuo S, Arroyo MP, Wang TS, Hurwitz J. 1999. The C-terminal region of Schizosaccaromyces pombe proliferating cell nuclear antigen is essential for DNA polymerase activity. Proceedings of the National Academy of Sciences of the United States of America 96(17): 9515-20.
On the possibility of constructive neutral evolution.
Stoltzfus A. 1999. On the possibility of constructive neutral evolution. Journal of molecular evolution 49(2): 169-81.
Relocation of the catalytic carboxylate group in class A beta-lactamase: the structure and function of the mutant enzyme Glu166-->Gln:Asn170-->Asp.
Chen CC, Herzberg O. 1999. Relocation of the catalytic carboxylate group in class A beta-lactamase: the structure and function of the mutant enzyme Glu166-->Gln:Asn170-->Asp. Protein engineering 12(7): 573-9.
Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
Turko IV, Ballard SA, Francis SH, Corbin JD. 1999. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds. Molecular pharmacology 56(1): 124-30.